肠易激综合征中血管与上皮屏障完整性丧失的分子机制
研究纳入78名健康对照和223例肠易激综合征(IBS)患者,评估上皮与血管屏障形态功能及其与症状感知的关联。IBS患者全胃肠道上皮屏障受损,结肠血管密度和血管通透性增加,IBS黏膜介质通过蛋白酶激活受体-2和组蛋白去乙酰化酶11下调血管内皮钙黏蛋白增加内皮通透性。通透性改变与肠道症状、行为症状及健康相关生活质量相关。
要点
- IBS患者全胃肠道上皮屏障受损,IBS可溶性介质下调紧密连接基因表达增加Caco-2通透性。
- IBS结肠黏膜血管密度和血管通透性增加,黏膜介质经蛋白酶激活受体-2和组蛋白去乙酰化酶11下调血管内皮钙黏蛋白。
- 通透性改变与IBS患者肠道症状、行为症状及健康相关生活质量相关。
核心结论
- IBS患者上皮和血管屏障受损,并参与临床表现。
研究设计与样本
- 研究纳入78名健康受试者(对照)和223例IBS患者,按验证问卷进行表型分型。
- 采用糖试验评估体内通透性,免疫组化、蛋白质印迹和电子显微镜表征血管屏障。
- 通过评估黏膜质膜囊泡相关蛋白-1和血管内皮钙黏蛋白表达评价血管通透性。
- 将Caco-2或人脐静脉内皮细胞单层与黏膜活检释放的可溶性介质共孵育以探讨通透性改变机制。
- 对实验与临床数据进行相关性分析。
主要发现
- IBS患者全胃肠道肠上皮屏障受损。
- IBS可溶性介质通过下调紧密连接基因表达增加Caco-2通透性。
- IBS结肠黏膜血管密度和血管通透性增加。
- IBS黏膜介质通过激活蛋白酶激活受体-2和组蛋白去乙酰化酶11增加人脐静脉内皮细胞单层通透性,导致血管内皮钙黏蛋白下调。
- 通透性改变与IBS患者肠道症状、行为症状及健康相关生活质量相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The pathophysiology of irritable bowel syndrome (IBS) is multifactorial and includes epithelial barrier dysfunction, a key element at the interface between the gut lumen and the deeper intestinal layers. Beneath the epithelial barrier there is the vascular one representing the last barrier to avoid luminal antigen dissemination The aims of this study were to correlate morpho-functional aspects of epithelial and vascular barriers with symptom perception in IBS. METHODS: Seventy-eight healthy subjects (controls) and 223 patients with IBS were enrolled in the study and phenotyped according to validated questionnaires. Sugar test was used to evaluate in vivo permeability. Immunohistochemistry, western blot, and electron microscopy were used to characterize the vascular barrier. Vascular permeability was evaluated by assessing the mucosal expression of plasmalemma vesicle-associated protein-1 and vascular endothelial cadherin. Caco-2 or human umbilical vein endothelial cell monolayers were incubated with soluble mediators released by mucosal biopsies to highlight the mechanisms involved in permeability alteration. Correlation analyses have been performed among experimental and clinical data. RESULTS: The intestinal epithelial barrier was compromised in patients with IBS throughout the gastrointestinal tract. IBS-soluble mediators increased Caco-2 permeability via a downregulation of tight junction gene expression. Blood vessel density and vascular permeability were increased in the IBS colonic mucosa. IBS mucosal mediators increased permeability in human umbilical vein endothelial cell monolayers through the activation of protease-activated receptor-2 and histone deacetylase 11, resulting in vascular endothelial cadherin downregulation. Permeability changes correlated with intestinal and behavioral symptoms and health-related quality of life of patients with IBS. CONCLUSIONS: Epithelial and vascular barriers are compromised in patients with IBS and contribute to clinical manifestations.
引用
- Barbaro MR, Cremon C, Marasco G, et al. Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome. Gastroenterology. 2024. PMID: 39004156. doi:10.1053/j.gastro.2024.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。